{"doi":"10.1101/2020.07.31.20165225","title":"Improved Sensitivity of Digits-in-Noise Test to High-Frequency Hearing Loss","abstract":"ABSTRACT Objectives Hearing loss is most commonly observed at high frequencies. High-frequency hearing loss (HFHL) precedes and predicts hearing loss at lower frequencies. It was previously shown that an automated, self-administered digits-in-noise (DIN) test can be sensitized for detection of HFHL by low-pass filtering the speech-shaped masking noise at 1.5 kHz. This study was designed to investigate whether sensitivity of the DIN to HFHL can be enhanced further using low-pass noise filters with higher cutoff frequencies. Design US-English digits 0-9, homogenized for audibility, were binaurally presented in different noise maskers including one broadband and three low-pass (cut-off at 2, 4, 8 kHz) filtered speech-shaped noises. DIN-Speech reception thresholds (SRTs) were obtained from 60 normal hearing (NH), and 40 mildly hearing impaired (HI) listeners with bilateral symmetric sensorineural hearing-loss. Standard and extended high frequency audiometric pure tone averages (PTAs) were compared with the DIN-SRTs. Results Narrower masking noise bandwidth generally produced better (more sensitive) mean DIN-SRTs. There were strong and significant correlations between SRT and PTA in the HI group. Lower frequency, PTA LF 0.5,1, 2, 4 kHz had the highest correlation and steepest slope with SRTs obtained from the 2 kHz filter. Higher frequency, PTA HF 4,8,10,12.5 kHz correlated best with SRTs obtained from 4 and 8 kHz filtered noise. The 4 kHz low-pass filter also had the highest sensitivity (92%) and equally-highest (with the 8 kHz filter) specificity (90%) for detecting an average PTA HF of 20 dB or more. Conclusions Of the filters used, DIN sensitivity to higher frequency hearing loss was greatest using the 4 kHz low-pass filter. These results suggest that low-pass filtered noise may be usefully substituted for broadband noise to improve earlier detection of HFHL using DIN.","journal":"medRxiv","year":2020,"id":125236,"datarank":0.0,"base_score":0.0,"endowment":0.0,"self_citation_contribution":0.0,"citation_network_contribution":0.0,"self_endowment_contribution":0.0,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":2,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":0.9572,"is_data_producer":false,"deposit_databanks":null,"is_oa":true,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":"2020-01-01","fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":390725,"name":"Noah H. Silbert","orcid":"0000-0003-2515-384X","position":1,"is_corresponding":false},{"id":571076,"name":"De Wet Swanepoel","orcid":"0000-0001-8313-1636","position":2,"is_corresponding":false},{"id":249796,"name":"David R. Moore","orcid":"0000-0002-1567-1945","position":3,"is_corresponding":false},{"id":249799,"name":"Lina Motlagh Zadeh","orcid":"0000-0001-7972-7138","position":0,"is_corresponding":true}],"reference_count":51,"raw_metadata":null,"created_at":"2026-07-18T23:15:15.482227Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}